Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.2 (
topoisomerase
)
9,166
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Physiological cell conditions of solid tumors, such as glucose starvation and hypoxia,induce cellular resistance to
topoisomerase
II-directed drugs. Here, we show that the induction of drug resistance is mediated by nuclear accumulation of proteasomes, large multicatalytic protease complexes. We found that the nuclear proteasome accumulation during glucose starvation was attenuated by stable expression of a mutant type of proteasome subunit,
XAPC7
, that lacked the nuclear localization signal (NLS). It is important that the expression of NLS-defective
XAPC7
also diminished the induction of resistance to etoposide and doxorubicin, typical
topoisomerase
II-directed drugs. Under normal conditions, however, the NLS-defective
XAPC7
had little effect on either nuclear proteasome distribution or etoposide sensitivity. Our findings demonstrate that stress-induced nuclear proteasome accumulation occurs through up-regulation of the NLS-dependent transport. Inhibition of the nuclear proteasome accumulation can be a novel approach to circumventing resistance to
topoisomerase
II-directed drugs.
...
PMID:Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase II-directed drugs. 1220 54